COMPANY
AEQUITA PHARMACY
AEQUITA PHARMACY: recalling firm for Semaglutide, Tirzepatide, as stated by public registers.
RECALLING FIRM
Recalled a product naming the peptide (FDA enforcement report).
| Semaglutide | Class II recall, Ongoing, 2025-08-13 Regulator openFDA |
|---|---|
| Tirzepatide | Class II recall, Ongoing, 2025-08-13 Regulator openFDA |
What a register states, not an endorsement or an accusation by this site. All companies.
WEEKLY
Register Watch, weekly
New trials, approvals and enforcement actions. One email a week.